Publication | Closed Access
SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression
32
Citations
39
References
2018
Year
InflammationMetabolic SyndromeSirt1 Activator E1231Lipid DisorderCardiovascular DiseaseCell SignalingMedicineImmunologyHyperlipidemiaVascular BiologyDyslipidemiaLipoprotein MetabolismExperimental AtherosclerosisPharmacologyCell BiologyAtherosclerosisAbca1 ExpressionLipid Synthesis
| Year | Citations | |
|---|---|---|
Page 1
Page 1